1. Glucoprivation increases estrogen receptor alpha immunoreactivity in the brain catecholaminergic neurons in ovariectomized rats.
- Author
-
Reyes BA, Estacio MA, I'Anson H, Tsukamura H, and Maeda KI
- Subjects
- Animals, Brain cytology, Brain drug effects, Brain Stem cytology, Brain Stem drug effects, Brain Stem metabolism, Deoxyglucose pharmacology, Dopamine beta-Hydroxylase, Estrogen Receptor alpha, Female, Glucose analogs & derivatives, Hypothalamus cytology, Hypothalamus drug effects, Hypothalamus metabolism, Immunohistochemistry, Luteinizing Hormone metabolism, Neurons cytology, Neurons drug effects, Ovariectomy, Rats, Rats, Wistar, Tyrosine 3-Monooxygenase metabolism, Brain metabolism, Catecholamines metabolism, Glucose deficiency, Neurons metabolism, Receptors, Estrogen metabolism
- Abstract
Estrogen-dependent enhancement of glucoprivic-induced luteinizing hormone (LH) suppression is hypothesized to be due to increased estrogen receptor alpha (ERalpha)-immunoreactive (ir) cells in specific brain nuclei in a manner similar to fasting. ERalpha expression in various brain areas was determined in ovariectomized rats after systemic 2-deoxy-D-glucose (2DG)-induced glucoprivation. Expression of ERalpha in catecholaminergic neurons in the lower brainstem was also examined. ERalpha-ir cells increased in hypothalamic paraventricular and periventricular nuclei, and A1 and A2 regions of the brainstem 1 h after 2DG injection. The percentage of ERalpha in the tyrosine hydroxylase (TH)- and dopamine-beta-hydroxylase (DBH)-ir neurons was higher in A1 and A2 regions of 2DG-treated rats, but the number of TH- and DBH-ir cells did not change. Thus, 2DG induces ERalpha expression in specific brain nuclei and expression of ERalpha in catecholaminergic neurons of the brainstem indicates a role for estrogen in activating those neurons projecting to the hypothalamic paraventricular nucleus to suppress LH secretion during glucoprivation.
- Published
- 2001
- Full Text
- View/download PDF